Triticum aestivum (Wheatgrass) formulation: An alternate treatment for thepatients with Thalassemia > Volume 07 - 2007

본문 바로가기

사이트 내 전체검색


 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001
 

Oriental Pharmacy and Experimental Medicine
Volume 07 - 2007
Date: 2008

Journal: Pages 466-476

February 2008 | Triticum aestivum (Wheatgrass) formulation: An alternate treatment for thepatients with Thalassemia…

TR Desai1, JK Solanki2,*, Pankaj Buch4 and RK Goyal3

첨부파일

Summary

​We have developed the tablet formulation of Triticum aestivum (wheatgrass) and investigatedclinically, its effects in patients suffering from b-thalassemia (major) at K. T. Children Hospital,Civil Hospital, Rajkot. The tablets (wheatgrass powder 250 mg.) were given 3 times in a day for9 months. Blood samples were collected at the start, after 6 months and 9 months and analyzedfor various biochemical and hematological parameters. Treatment with wheatgrass formulationfor 9 months produced significant decrease in hemoglobin, total RBC, eosinophil and reticulocytecounts. The mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration(MCHC) were significantly increased was significantly increased. The serum ferritin was alsosignificantly decreased. There was no influence on serum magnesium, serum iron and Thiobarbituric acidreacting substances (TBARS). Our data indicate that treatment with wheatgrass on patients withß-thalassemia (major) may have beneficial effects in the form of a decrease in ineffectiveerythropoiesis, stimulation of hemoglobin synthesis in RBC, decrease in iron load and decrease ineosinophil count.


This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View